Article
Clinicopathologic and genetic analysis of invasive breast carcinomas in women with germline CHEK2 variants.
Breast cancer research and treatment - 1 Feb 2024
Schwartz Christopher J, Khorsandi Nikka, Blanco Amie, Mukhtar Rita A, Chen Yunn-Yi, Krings Gregor
Abstract excerpt
PURPOSE: Germline pathogenic variants in checkpoint kinase 2 (CHEK2) are associated with a moderately increased risk of breast cancer (BC). The spectrum of clinicopathologic features and genetics of these tumors has not been fully established. METHODS: We characterized the histopathologic and clinicopathologic features of 44 CHEK2-associated BCs from 35 women, and assessed responses to neoadjuvant chemotherapy. A...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
